Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR2 | Q92731 | 3/20 | 0.38 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | NR1I2 | O75469 | 2/20 | 0.32 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.31 |
| ▸ | DRD3 | P35462 | 2/20 | 0.31 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.31 |
| ▸ | DRD2 | P14416 | 1/20 | 0.31 |
| ▸ | DRD4 | P21917 | 1/20 | 0.31 |
| ▸ | CA12 | O43570 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | KCNA5 | P22460 | 1/20 | 0.31 |
| ▸ | KCNN4 | O15554 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3438894 | 0.76 | — | — | |
| SCHEMBL22517371 | 0.75 | ALDH1A1 (0.44) | ALDH1A1HTTCA2 | |
| SCHEMBL10149841 | 0.71 | MMP3 (0.48) | TAAR1OPRM1DRD3 | |
| SCHEMBL3676594 | 0.70 | TAAR1 (0.38) | TAAR1KCNA5KCNN4 | |
| Tert-Butylbenzene SCHEMBL28295420 | 0.69 | HSD11B1 (0.38) | ALDH1A1HTTNR3C2CA2CA9 | |
| SCHEMBL3438914 | 0.69 | AOC3 (0.37) | TAAR1 | |
| SCHEMBL10781243 | 0.67 | TAAR1 (0.54) | TAAR1ALDH1A1OPRM1DRD3DRD2 | |
| SCHEMBL30983152 | 0.67 | ESR2 (0.35) | ESR2NR1I2CA12CA2CA9 | |
| SCHEMBL22517676 | 0.66 | TSHR (0.36) | TAAR1ALDH1A1OPRM1 | |
| SCHEMBL15786468 | 0.65 | TAAR1 (0.47) | ESR2TAAR1ALDH1A1HTTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11161827-B2 | Catalytic systems for stereoselective synthesis of chiral amines by enantiodivergent radical C—H amination | THE TRUSTEES OF BOSTON COLLEGE (MA) | 2021-11-02 | — | — | US | disclosed |
| US-20200317627-A1 | CATALYTIC SYSTEMS FOR STEREOSELECTIVE SYNTHESIS OF CHIRAL AMINES BY ENANTIODIVERGENT RADICAL C-H AMINATION | TRUSTEES OF BOSTON COLLEGE (US) | 2020-10-08 | — | — | US | disclosed |
| US-20120101271-A1 | DIAMINE SYNTHESIS VIA CATALYTIC C-H AMINATION OF AZIDES | NATIONAL SCIENCE FOUNDATION | 2012-04-26 | — | — | US | disclosed |
| US-20120101271-A1 | DIAMINE SYNTHESIS VIA CATALYTIC C-H AMINATION OF AZIDES | NATIONAL SCIENCE FOUNDATION | 2012-04-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11161827-B2 | Catalytic systems for stereoselective synthesis of chiral amines by enantiodivergent radical C—H amination | STS, SRM, SCLY | ESR2 2783/4885TAAR1 935/4885ALDH1A1 725/4885 |
| US-20200317627-A1 | CATALYTIC SYSTEMS FOR STEREOSELECTIVE SYNTHESIS OF CHIRAL AMINES BY ENANTIODIVERGENT RADICAL C-H AMINATION | STS, SCLY, SRM | ESR2 2816/4885TAAR1 934/4885ALDH1A1 742/4885 |
| US-20120101271-A1 | DIAMINE SYNTHESIS VIA CATALYTIC C-H AMINATION OF AZIDES | DOHH, AOC1, ESD | ESR2 4106/4885TAAR1 800/4885ALDH1A1 233/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.